Deregulation of O-GlcNAcylation is a feature of human disorders including diabetes, cancer, and Alzheimer’s disease [10,15], in addition to the congenital disorder associated with OGT mutations: OGT-X-linked intellectual disability (XLID) [16,17]. This evidence concerns the gene OGT and cancer.